In December, CombiGene's shareholders will vote on the company's future direction. Chairman Jonas Ekblom and CEO Peter Ekolind presents the conditions and answer questions from viewers. The interview is moderated by Västra Hamnen's analyst Tobias Karlsson. The video is in Swedish.

CombiGene's CEO Peter Ekolind comments on the recent strategic decisions on CG01, the focus on gene therapy and the introduction of a cost reduction program.

CEO Peter Ekolind presents the latests report and answers questions from the viewers and Västra Hamnen's Chief Analyst Martin Dominique. The video is in Swedish.